Studies Transgender
Studies Gender Dysphoria
1 reported clinical trial
1 drug studied

Clinical Trials Rena Xu is currently running

Image of trial facility.

Digital Platform

for Transgender Mental Health

This is a randomized controlled trial to test the effectiveness of an interactive educational app-based digital intervention that provides knowledge and support to transgender and gender-diverse (TGD) young adults ages 18-24 years and their caregivers. The goal of the study is to examine the effects of exposure to the app on TGD young adult mental health outcomes. Participants will be randomized to an Immediate Arm (access to a digital platform, plus usual care) or a Deferred Arm (usual care; access to the digital platform at 6 mo). Usual care consists of access to published resources and community support organizations, if available. The list of resources will include contact information for a suicide prevention hotline. For each Arm, the intervention period will last 6 months, followed by 9 months of observation, during which access to the intervention is maintained. Assessments will be performed every 3 months over the 15 month period to document changes in mental health outcomes, and the two groups will be compared. The investigators plan to enroll 500 TGD young adults and their caregivers, with at least 50% (250 participants) to identify as Black, Indigenous, People of Color (BIPOC) and 50% (125 TGD young adults, 125 caregivers) to be young adult-caregiver dyads. Ongoing process reassessments will be performed to maximize effectiveness of the intervention, including focus groups and in-depth interviews with TGD young adults, caregivers, and providers, as well as analysis of data collected through the digital platform and participant surveys. Investigators will account for sociodemographic characteristics such as race and ethnicity, age, gender identity, education status, existing mental health conditions, and history of suicidal ideation or attempt. Data will be analyzed across racial minority groups to ensure that the intervention is effective for all racial minorities; if there are discrepancies in effectiveness, additional mixed methods evaluation will be performed to identify and address potential causes.
Recruiting1 award N/A1 criteria

More about Rena Xu

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Rena Xu has experience with
  • Interactive Educational Digital Platform For Transgender And Gender-diverse (TGD) Young Adults And Caregivers
Breakdown of trials Rena Xu has run
Health Services for Transgender Persons

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rena Xu specialize in?
Rena Xu focuses on Transgender and Gender Dysphoria. In particular, much of their work with Transgender has involved treating patients, or patients who are undergoing treatment.
Is Rena Xu currently recruiting for clinical trials?
Yes, Rena Xu is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Rena Xu has studied deeply?
Yes, Rena Xu has studied treatments such as Interactive educational digital platform for transgender and gender-diverse (TGD) young adults and caregivers.
What is the best way to schedule an appointment with Rena Xu?
Apply for one of the trials that Rena Xu is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.